Trial literature on soft tissue sarcoma

Last modification: 2024/05/03 https://kinderkrebsinfo.de/doi/e123835

Trial literature on soft tissue sarcomas

Pubmed

  1. Sparber-Sauer M, Corradini N, Affinita MC, Milano GM, Pierron G, Carton M, Tirode F, Pissaloux D, Alaggio R, Vokuhl C, Bisogno G, Berlanga P, Ferrari A, Orbach D: Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis. Cancer medicine 2023, 12: 14346 [PMID: 37212486] SPA2023b
  2. Heinz AT, Schönstein A, Ebinger M, Fuchs J, Timmermann B, Seitz G, Vokuhl C, Münter M, Pajtler KW, Stegmaier S, von Kalle T, Kratz CP, Ljungman G, Juntti H, Klingebiel T, Koscielniak E, Sparber-Sauer M, Cooperative Weichteilsarkom Studiengruppe: Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR. Pediatric blood & cancer 2023,:e30707 [PMID: 37814424] HEI2023b
  3. Sparber-Sauer M, Ferrari A, Spunt SL, Vokuhl C, Casey D, Lautz TB, Meyer WH, Walterhouse DO, Pajtler KW, Alaggio R, Schmidt A, Safwat A, Timmermann B, Dall'Igna P, Chen S, Weiss AR, Orbach D: The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT). Cancer medicine 2023, 12: 11719 [PMID: 36744538] SPA2023a
  4. Heinz AT, Ebinger M, Schönstein A, Fuchs J, Timmermann B, Seitz G, Vokuhl C, Münter MW, Pajtler KW, Stegmaier S, von Kalle T, Kratz CP, Rößler J, Ljungman G, Klingebiel T, Koscielniak E, Sparber-Sauer M, Cooperative Weichteilsarkom Studiengruppe (CWS): Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR). Pediatric blood & cancer 2023, 70:e30363 [PMID: 37066598] HEI2023a
  5. Carton M, Del Castillo JP, Colin JB, Kurtinecz M, Feuilly M, Pierron G, Arvis P, Khadir SK, Sparber-Sauer M, Orbach D: Larotrectinib versus historical standard of care in patients with infantile fibrosarcoma: protocol of EPI-VITRAKVI. Future oncology (London, England) 2023, 19: 1645 [PMID: 37133249] CAR2023a
  6. Schoot RA, van Ewijk R, von Witzleben AA, Kao SC, Merks JHMH, Morosi C, Pace E, Shulkin BL, Ferrari A, von Kalle T, van Rijn RR, Weiss AR, Sparber-Sauer M, Ter Horst SAJ, McCarville MB: INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma. European journal of radiology 2023, 166: 111012 [PMID: 37541182] SCH2023a
  7. Bisogno G, Fuchs J, Dasgupta R, Ferrari A, Haduong JH, Rogers T, Walterhouse DO, Coppadoro B, Xue W, Vokuhl C, Hawkins DS, Seitz G, Merks JHM, Sparber-Sauer M, Venkatramani R: Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy. Cancer 2022, 128: 4150 [PMID: 36250420] BIS2023
  8. Maennlin S, Chaika M, Gassenmaier S, Grimm R, Sparber-Sauer M, Fuchs J, Schmidt A, Ebinger M, Hettmer S, Gatidids S, Dittmann H, Schäfer JF: Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma. Pediatric radiology 2023, 53: 438 [PMID: 36399161] MAE2023
  9. Eichholz T, Döring M, Giardino S, Gruhn B, Seitz C, Flaadt T, Schwinger W, Ebinger M, Holzer U, Mezger M, Teltschik HM, Sparber-Sauer M, Koscielniak E, Abele M, Handgretinger R, Lang P: Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas. Frontiers in oncology 2023, 13: 1064190 [PMID: 36895486] EIC2023
  10. Koscielniak E, Timmermann B, Münter M, Weclawek-Tompol J, Ladenstein R, Niggli F, Ljungman G, Brecht IB, Blank B, Hallmen E, Scheer M, Fuchs J, Seitz G, Blattmann C, Sparber-Sauer M, Klingebiel T: Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry. Journal of clinical oncology 2023, 41: 4916 [PMID: 37725766] KOS2023
  11. Sparber-Sauer M, Dietzschold M, Schönstein A, Heinz A, Vokuhl C, Pajtler KW, Harrabi S, Lin YL, Kalle TV, Hagen R, Ladenstein R, Kazanowska B, Ljungman G, Klingebiel T, Ebinger M, Koscielniak E, Münter M, Timmermann B, CWS Study Group: Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Pediatric blood & cancer 2023,:e30742 [PMID: 37880926] SPA2023
  12. Tramsen L, Bochennek K, Sparber-Sauer M, Salzmann-Manrique E, Scheer M, Dantonello T, Borkhardt A, Dirksen U, Thorwarth A, Greiner J, Ebinger M, Weclawek-Tompol J, Ladenstein R, Ljungman G, Hallmen E, Lehrnbecher T, Koscielniak E, Klingebiel T: Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers 2023, 15 [PMID: 37046711] TRA2023
  13. Schober SJ, Hallmen E, Reßle F, Gassmann H, Prexler C, Wawer A, von Luettichau I, Ladenstein R, Kazanowska B, Ljungman G, Niggli F, Lohi O, Hauer J, Gruhn B, Klingebiel T, Bader P, Burdach S, Lang P, Sparber-Sauer M, Koscielniak E, Thiel U: No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy. Frontiers in oncology 2022, 12: 878367 [PMID: 35619911] SCH2022g
  14. Scheer M, Hallmen E, Vokuhl C, Fuchs J, Tunn PU, Münter M, Timmermann B, Bauer S, Henssen AG, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Eggert A, Klingebiel T, Koscielniak E, Cooperative Weichteilsarkom Studiengruppe [CWS]: Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma. Journal of cancer research and clinical oncology 2023, 149: 1717 [PMID: 35687182] SCH2022f
  15. Sparber-Sauer M: The future of rhabdomyosarcoma trials. The Lancet 2022, 6: 510 [PMID: 35690070] SPA2022c
  16. Koscielniak E, Blank B, Vokuhl C, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Handgretinger R, Seitz G, Fuchs J, Fröhlich B, Scheer M, Wessalowski R, Schmid I, Sparber-Sauer M, Klingebiel T: Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol. Cancers 2022, 14 [PMID: 35205646] KOS2022a
  17. Ferrari A, Spunt SL, Sparber-Sauer M, Walterhouse DO, Pajtler KW, Meyer WH, Orbach D, Weiss A: Controversies and challenges in the management of paediatric non-rhabdomyosarcoma soft tissue sarcomas. The Lancet 2022, 6: 221 [PMID: 35176224] FER2022a
  18. Sparber-Sauer M: [Genomic classification and survival of patients with rhabdomyosarcoma: a report from an international consortium]. Strahlentherapie und Onkologie 2022, 198: 404 [PMID: 35230459] SPA2022a
  19. Stegmaier S, Sparber-Sauer M, Aakcha-Rudel E, Münch P, Reeh T, Feuchtgruber S, Hallmen E, Blattmann C, Bielack S, Klingebiel T, Koscielniak E: Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer 2022, 69:e29652 [PMID: 35338758] STE2022
  20. Whittle S, Venkatramani R, Schönstein A, Pack SD, Alaggio R, Vokuhl C, Rudzinski ER, Wulf AL, Zin A, Gruver JR, Arnold MA, Merks JHM, Hettmer S, Koscielniak E, Barr FG, Hawkins DS, Bisogno G, Sparber-Sauer M: Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis. European journal of cancer 2022, 168: 56 [PMID: 35452896] WHI2022
  21. Ferrari A, Orbach D, Sparber-Sauer M, Walterhouse DO, Pajtler KW, Meyer WH, Spunt SL, Weiss AR: The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium. European journal of cancer 2022, 169: 10 [PMID: 35490564] FER2022
  22. Hettmer S, Linardic CM, Kelsey A, Rudzinski ER, Vokuhl C, Selfe J, Ruhen O, Shern JF, Khan J, Kovach AR, Lupo PJ, Gatz SA, Schäfer BW, Volchenboum S, Minard-Colin V, Koscielniak E, Hawkins DS, Bisogno G, Sparber-Sauer M, Venkatramani R, Merks JHM, Shipley J: Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. European journal of cancer (Oxford, England : 1990) 2022, 172: 367 [PMID: 35839732] HET2022
  23. Kube SJ, Blattmann C, Bielack SS, Kager L, Kaatsch P, Kühne T, Sorg B, Kevric M, Jabar S, Hallmen E, Sparber-Sauer M, Klingebiel T, Koscielniak E, Dirksen U, Hecker-Nolting S, Gerß JWO: Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. Cancer 2022, 128: 1787 [PMID: 35195899] KUB2022
  24. Sparber-Sauer M, Ferrari A, Kosztyla D, Ladenstein R, Cecchetto G, Kazanowska B, Scarzello G, Ljungman G, Milano GM, Niggli F, Alaggio R, Vokuhl C, Casanova M, Klingebiel T, Zin A, Koscielniak E, Bisogno G: Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults. Pediatric blood & cancer 2022 Apr 19;:e29691 [PMID: 35441463] SPA2022
  25. Scheer M, Vokuhl C, Bauer S, Fuchs J, Loff S, Timmermann B, Münter M, Henssen AG, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Koscielniak E, Klingebiel T, European Cooperative Weichteilsarkom Studiengruppe [CWS]: The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents. Journal of cancer research and clinical oncology 2021 Jul 17; online ahead of print [PMID: 34272609] SCH2021c
  26. Sparber-Sauer M, Orbach D, Navid F, Hettmer S, Skapek S, Corradini N, Casanova M, Weiss A, Schwab M, Ferrari A: Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis. British journal of cancer 2021, 124: 1637 [PMID: 33723397] SPA2021b
  27. Hauer J, Fischer U, Borkhardt A: Toward prevention of childhood ALL by early-life immune training. Blood 2021, 138: 1412 [PMID: 34010407] HAU2021
  28. Sparber-Sauer M, Tagarelli A, Seitz G, Sorg B, Bien E, Bel-Ami T, Pourtsidis A, Lopez Almaraz R, Koscielniak E, Ferrari A, Orbach D, Bisogno G, EXPeRT and CWS Study Groups: Children with progressive and relapsed pleuropulmonary blastoma: A European collaborative analysis. Pediatric blood & cancer 2021, 68:e29268 [PMID: 34486213] SPA2021
  29. Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Leuschner I, Scheer M, Münter M, Ljungman G, Bielack SS, Niggli F, Ladenstein R, Klingebiel T, Fuchs J, Koscielniak E, CWS Study Group: Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer 2018, 65:e26943 [PMID: 29316163] SPA2021
  30. Rudzinski ER, Kelsey A, Vokuhl C, Linardic CM, Shipley J, Hettmer S, Koscielniak E, Hawkins DS, Bisogno G: Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe. Pediatric blood & cancer 2021, 68:e28798 [PMID: 33306276] RUD2021
  31. Koscielniak E, Sparber-Sauer M, Scheer M, Vokuhl C, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Paulussen M, Bielack SS, Seitz G, Fuchs J, Hallmen E, Klingebiel T, On Behalf Of The Cws Study Group: Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS). Pediatric blood & cancer 2021,e29145 [PMID: 34089219] KOS2021
  32. Scheer M, Vokuhl C, Veit-Friedrich I, Münter M, von Kalle T, Greulich M, Loff S, Stegmaier S, Sparber-Sauer M, Niggli F, Ladenstein R, Kazanowska B, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Koscielniak E, Klingebiel T, Cooperative Weichteilsarkom Studiengruppe (CWS): Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer 2020, 67:e28009 [PMID: 31736251] SCH2020d
  33. Scheer M, Blank B, Bauer S, Vokuhl C, Stegmaier S, Feuchtgruber S, Henssen A, Sparber-Sauer M, Eggert A, Handgretinger R, Pekrun A, Rossig C, Rutkowski S, Schlegel PG, Schrappe M, Simon T, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Koscielniak E, Klingebiel T, Cooperative Weichteilsarkom Studiengruppe [CWS]: Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Journal of cancer research and clinical oncology 2020, 146: 953 [PMID: 31932909] SCH2020b
  34. Sparber-Sauer M, Vokuhl C, Seitz G, Stegmaier S, Hallmen E, von Kalle T, Scheer M, Münter M, Bielack SS, Ladenstein R, Niggli F, Ljungman G, Fuchs J, Klingebiel T, Koscielniak E, CWS Study Group: The impact of local control in the treatment of children with advanced infantile and adult-type fibrosarcoma: Experience of the cooperative weichteilsarkom studiengruppe (CWS). Journal of pediatric surgery 2020, 55: 1740 [PMID: 31753608] SPA2020a
  35. Sparber-Sauer M, Koscielniak E, Vokuhl C, Schmid I, Bien E, Seitz G, Hallmen E, von Kalle T, Scheer M, Münter M, Bielack SS, Niggli F, Ljungman G, Fuchs J, Hettmer S, Rössler J, Klingebiel T, CWS Study Group: Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Pediatric blood & cancer 2020, 67:e28095 [PMID: 31814291] SPA2020
  36. Koscielniak E, Klingebiel T: A new standard of care for patients with high-risk rhabdomyosarcoma? The Lancet. Oncology 2020, 21:e1 [PMID: 31908295] KOS2020
  37. Krewer J, Rolle U, Koscielniak E, Vokuhl C, Mentzel T, Seitz G, Feuchtgruber S, von Kalle T, Scheer M, Münter M, Bielack SS, Fuchs J, Niggli F, Hettmer S, Klingebiel T, Sparber-Sauer M, CWS Study Group: Dermatofibrosarcoma protuberans in children and adolescents: Primary and Relapsed disease-Experience of the Cooperative Weichteilsarkomstudiengruppe (CWS). Journal of surgical oncology 2020, 122: 263 [PMID: 32430916] KRE2020
  38. Murawski M, Scheer M, Leuschner I, Stefanowicz J, Bonar J, Dembowska-Bagińska B, Kaliciński P, Koscielniak E, Czauderna P, Fuchs J: Undifferentiated sarcoma of the liver: Multicenter international experience of the Cooperative Soft-Tissue Sarcoma Group and Polish Paediatric Solid Tumor Group. Pediatric blood & cancer 2020, 67:e28598 [PMID: 32706511] MUR2020
  39. Lautz TB, Martelli H, Fuchs J, Chargari C, Smeulders N, Granberg CF, Wolden SL, Sparber-Sauer M, Hawkins DS, Bisogno G, Koscielniak E, Rodeberg DA, Seitz G, INSTRuCT group: Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe. Pediatric blood & cancer 2020,:e28601 [PMID: 32762004] LAU2020
  40. Orbach D, Sparber-Sauer M, Laetsch TW, Minard-Colin V, Bielack SS, Casanova M, Corradini N, Koscielniak E, Scheer M, Hettmer S, Bisogno G, Hawkins DS, Ferrari A: Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies. European journal of cancer 2020, 137: 183 [PMID: 32784118] ORB2020
  41. Meister MT, Scheer M, Hallmen E, Stegmaier S, Vokuhl C, von Kalle T, Fuchs J, Münter M, Niggli F, Ladenstein R, Kazanowska B, Ljungman G, Bielack S, Koscielniak E, Klingebiel T, Cooperative Weichteilsarkom Studiengruppe [CWS]: Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Journal of surgical oncology 2020, 122: 1337 [PMID: 32812260] MEI2020
  42. Merker M, Wagner J, Kreyenberg H, Heim C, Moser LM, Wels WS, Bonig H, Ivics Z, Ullrich E, Klingebiel T, Bader P, Rettinger E: ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma. Frontiers in immunology 2020, 11: 581468 [PMID: 33193388] MER2020
  43. Moreno L, Barone G, DuBois SG, Molenaar J, Fischer M, Schulte J, Eggert A, Schleiermacher G, Speleman F, Chesler L, Geoerger B, Hogarty MD, Irwin MS, Bird N, Blanchard GB, Buckland S, Caron H, Davis S, De Wilde B, Deubzer HE, Dolman E, Eilers M, George RE, George S, Jaroslav Š, Maris JM, Marshall L, Merchant M, Mortimer P, Owens C, Philpott A, Poon E, Shay JW, Tonelli R, Valteau-Couanet D, Vassal G, Park JR, Pearson ADJ: Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. European journal of cancer (Oxford, England : 1990) 2020, 136: 52 [PMID: 32653773] MOR2020
  44. Sparber-Sauer M, Stegmaier S, Vokuhl C, Seitz G, von Kalle T, Scheer M, Münter M, Bielack SS, Weclawek-Tompol J, Ladenstein R, Niggli F, Ljungman G, Fuchs J, Hettmer S, Koscielniak E, Klingebiel T, CWS Study Group: Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer 2019, 66:e27652 [PMID: 30762282] SPA2019a
  45. Urla C, Warmann SW, Sparber-Sauer M, Schuck A, Leuschner I, Klingebiel T, Blumenstock G, Seitz G, Koscielniak E, Fuchs J: Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS). BMC cancer 2019, 19: 945 [PMID: 31610788] URL2019
  46. Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Leuschner I, Scheer M, Münter M, Ljungman G, Bielack SS, Niggli F, Ladenstein R, Klingebiel T, Fuchs J, Koscielniak E, CWS Study Group: Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer 2018, 65:e26943 [PMID: 29316163] SPA2018
  47. Dantonello TM, Stark M, Timmermann B, Fuchs J, Selle B, Linderkamp C, Handgretinger R, Hagen R, Feuchtgruber S, Kube S, Kosztyla D, Kazanowska B, Ladenstein R, Niggli F, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E, Cooperative Weichteilsarkom Studiengruppe [CWS]: Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. Pediatric blood & cancer 2015, 62: 16 [PMID: 25263634] DAN2015
  48. Seitz G, Dantonello TM, Kosztyla D, Klingebiel T, Leuschner I, Fuchs J, Koscielniak E, Cooperative Soft Tissue Sarcoma Study Group: Impact of Hemiscrotectomy on Outcome of Patients with Embryonal Paratesticular Rhabdomyosarcoma: Results from the Cooperative Soft Tissue Sarcoma Group Studies CWS-86, 91, 96 and 2002P. The Journal of urology 2014, Epub ahead of print [PMID: 24631108] SEI2014a
  49. Dantonello TM, Lochbühler H, Schuck A, Kube S, Godzinski J, Sköldenberg E, Ljungman G, Kosztyla D, Veit-Friedrich I, Hallmen E, Feuchtgruber S, Wessalowski R, Franke M, Bielack SS, Klingebiel T, Koscielniak E: Challenges in the Local Treatment of Large Abdominal Embryonal Rhabdomyosarcoma. Annals of surgical oncology 2014, Epub ahead of print [PMID: 25047462] DAN2014a
  50. Dantonello TM, Leuschner I, Vokuhl C, Gfroerer S, Schuck A, Kube S, Nathrath M, Bernbeck B, Kaatsch P, Pal N, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E, CWS: Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer 2013, 60: 224 [PMID: 22535600] DAN2013a
  51. Dantonello TM, Int-Veen C, Schuck A, Seitz G, Leuschner I, Nathrath M, Schlegel PG, Kontny U, Behnisch W, Veit-Friedrich I, Kube S, Hallmen E, Kazanowska B, Ladenstein R, Paulussen M, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E, on behalf of the Cooperative Weichteilsarkom Studiengruppe (CWS): Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma. Pediatr Blood Cancer 2013, 60: 1267 [PMID: 23418028] DAN2013
  52. Nitz A, Kontopantelis E, Bielack S, Koscielniak E, Klingebiel T, Langer T, Paulides M: Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients. Oncology letters 2013, 5: 311 [PMID: 23255940] NIT2013
  53. Siepermann M, Koscielniak E, Dantonello T, Klee D, Boos J, Krefeld B, Borkhardt A, Hoehn T, Asea A, Wessalowski R: Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatric blood & cancer 2012, 58: 104 [PMID: 22076833] SIE2012
  54. Dantonello TM, Leuschner I, Vokuhl C, Gfroerer S, Schuck A, Kube S, Nathrath M, Bernbeck B, Kaatsch P, Pal N, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E, on behalf of CWS: Malignant ectomesenchymoma in children and adolescents: Report from the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer 2012, [Epub ahead of print] [PMID: 22535600] DAN2012
  55. Seitz G, Dantonello TM, Int-Veen C, Blumenstock G, Godzinski J, Klingebiel T, Schuck A, Leuschner I, Koscielniak E, Fuchs J, on behalf of the CWS-96 Study Group: Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma trial CWS-96. Pediatr Blood Cancer 2011, 56: 718 [PMID: 21370402] SEI2011a
  56. Dantonello TM, Winkler P, Boelling T, Friedel G, Schmid I, Mattke AC, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E, CWS Study Group: Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group. Pediatr Blood Cancer 2011, 56: 725 [PMID: 21370403] DAN2011
  57. Benesch M, Leuschner I, Wardelmann E, Thielen M, Schmid I, Kontny U, Ebetsberger G, Frey E, Graf N, Schneider DT, Kremens B, Amann G, Urban C, Schlemmer M, Quehenberger F, Klingebiel T, Dantonello T, Koscielniak E: Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS). Eur J Cancer 2011, 47: 1692-8. Epub 2011 Apr 11. [PMID: 21486690] BEN2011
  58. Siepermann M, Koscielniak E, Dantonello T, Klee D, Boos J, Krefeld B, Borkhardt A, Hoehn T, Asea A, Wessalowski R: Oral low-dose chemotherapy: Successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatr Blood Cancer 2011, [Epub ahead of print] [PMID: 21241005] SIE2011
  59. Stegmaier S, Poremba C, Schaefer KL, Leuschner I, Kazanowska B, Békássy AN, Bielack SS, Klingebiel T, Koscielniak E: Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma study group (CWS). Pediatr Blood Cancer 2011, 57: 406 [PMID: 21254373] STE2011
  60. Bien E, Kazanowska B, Dantonello T, Adamkiewicz-Drozynska E, Balcerska A, Madziara W, Rybczynska A, Nurzynska-Flak J, Solarz E, Kurylak A, Zalewska-Szewczyk B, Krawczyk M, Izycka-Swieszewska E, Rapala M, Koscielniak E: Factors predicting survival in childhood malignant and intermediate vascular tumors : retrospective analysis of the Polish and German cooperative paediatric soft tissue sarcoma study groups and review of the literature. Ann Surg Oncol 2010, 17: 1878 [PMID: 20333551] BIE2010c
  61. Kuçi S, Rettinger E, Voss B, Weber G, Stais M, Kreyenberg H, Willasch A, Kuçi Z, Koscielniak E, Klöss S, von Laer D, Klingebiel T, Bader P: Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation. Haematologica 95: 1579 [PMID: 20378565] KUC2010
  62. Dantonello TM, Winkler P, Boelling T, Friedel G, Schmid I, Mattke AC, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E, on behalf of the CWS Study Group: Embryonal rhabdomyosarcoma with metastases confined to the lungs: Report from the CWS Study Group. Pediatr Blood Cancer 2010, [Epub ahead of print] [PMID: 21061312] DAN2010
  63. Mattke AC, Bailey EJ, Schuck A, Dantonello T, Leuschner I, Klingebiel T, Treuner J, Koscielniak E: Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatric blood & cancer 2009, 52: 772 [PMID: 19165889] MAT2009
  64. Dantonello TM, Int-Veen C, Harms D, Leuschner I, Schmidt BF, Herbst M, Jürgens H, Scheel-Walter HG, Bielack SS, Klingebiel T, Dickerhoff R, Kirsch S, Brecht I, Schmelzle R, Greulich M, Gadner H, Greiner J, Marky I, Treuner J, Koscielniak E: Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. Journal of clinical oncology 2009, 27: 1446 [PMID: 19224858] DAN2009
  65. Dantonello TM, Int-Veen C, Winkler P, Leuschner I, Schuck A, Schmidt BF, Lochbuehler H, Kirsch S, Hallmen E, Veit-Friedrich I, Bielack SS, Niggli F, Kazanowska B, Ladenstein R, Wiebe T, Klingebiel T, Treuner J, Koscielniak E: Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. Journal of clinical oncology 2008, 26: 406 [PMID: 18202417] DAN2008a
  66. Reiter A, Klapper W: Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. British journal of haematology 2008, 142: 329 [PMID: 18537979] REI2008
  67. Weihkopf T, Blettner M, Dantonello T, Jung I, Klingebiel T, Koscielniak E, Lückel M, Spix C, Kaatsch P: Incidence and time trends of soft tissue sarcomas in German children 1985-2004 - a report from the population-based German Childhood Cancer Registry. European journal of cancer 2008, 44: 432 [PMID: 18077150] WEI2008
  68. Klingebiel T, Boos J, Beske F, Hallmen E, Int-Veen C, Dantonello T, Treuner J, Gadner H, Marky I, Kazanowska B, Koscielniak E: Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatric blood & cancer 2008, 50: 739 [PMID: 18286501] KLI2008
  69. Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Jürgens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C: Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. European journal of cancer (Oxford, England : 1990) 2008, 44: 699 [PMID: 18294840] SCH2008
  70. Dantonello TM, Int-Veen C, Leuschner I, Schuck A, Furtwaengler R, Claviez A, Schneider DT, Klingebiel T, Bielack SS, Koscielniak E: Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults : experiences of the CWS and COSS study groups. Cancer 2008, 112: 2424 [PMID: 18438777] DAN2008
  71. Koscielniak E, Treuner J: Weichteilsarkome. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und Leitlinien und der Gesellschaft für Pädiatrische Onkologie und Hämatologie 2008 [URI: http://www.uni-duesseldorf.de/ AWMF/ ll/ 025-007.htm] KOS2008
  72. Stöhr W, Paulides M, Bielack S, Jürgens H, Koscielniak E, Rossi R, Langer T, Beck JD: Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Pediatric blood & cancer 2007, 48: 140 [PMID: 16724313] STO2007a
  73. Gieseke F, Schütt B, Viebahn S, Koscielniak E, Friedrich W, Handgretinger R, Müller I: Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood 2007, 110: 2197 [PMID: 17522338] GIE2007
  74. Hanke CA, Roessler J, Stegmaier S, Koscielniak E, Niemeyer CM, Kontny U: Alveolar rhabdomyosarcoma mimicking lymphoma with bone marrow involvement. European journal of pediatrics 2007, 166: 505 [PMID: 17008999] HAN2007
  75. Kazanowska B, Reich A, Stegmaier S, Békássy AN, Leuschner I, Chybicka A, Koscielniak E: Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children. Fetal and pediatric pathology 2007, 26: 17 [PMID: 17613043] KAZ2007
  76. Paulides M, Dörr HG, Stöhr W, Bielack S, Koscielniak E, Klingebiel T, Jürgens H, Bölling T, Willich N, Sauer R, Langer T, Beck JD, Late Effects Surveillance System: Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clinical endocrinology 2007, 66: 727 [PMID: 17381483] PAU2007
  77. Stöhr W, Paulides M, Bielack S, Jürgens H, Treuner J, Rossi R, Langer T, Beck JD: Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatric blood & cancer 2007, 48: 447 [PMID: 16628552] STO2007
  78. Wachtel M, Runge T, Leuschner I, Stegmaier S, Koscielniak E, Treuner J, Odermatt B, Behnke S, Niggli FK, Schäfer BW: Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. Journal of clinical oncology 2006, 24: 816 [PMID: 16391296] WAC2006